Towards the targeted management of Chediak-Higashi syndrome

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Lozano, Maria L ^a   Rivera, Jose ^a   Sánchez Guiu, Isabel ^a   Vicente, Vicente ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Chediak Higashi syndrome; CTL cytotoxicity; Hemophagocytic lymphohistiocytosis; LYST CHS1; Phenotype genotype correlation

Indexed keywords

ALLOTRANSPLANTATION; CHEDIAK HIGASHI SYNDROME; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE COURSE; GENOTYPE PHENOTYPE CORRELATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LYMPHOCYTE FUNCTION; MISSENSE MUTATION; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; REVIEW; CHEDIAK-HIGASHI SYNDROME; PATHOPHYSIOLOGY;

CHEDIAK-HIGASHI SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;

EID: 84908345027     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-014-0132-6     Document Type: Review

References (80)

1. Neutropenia crónica maligna familiar con granulaciones atípicas de los leucocitos. AB Beguez-Cesar, Boletín de la Sociedad Cubana de Pediatría 1943 15 900 922
2. Nouvelle anomalie leucocytaire de caractere constitutionnel et familial [New leukocyte anomaly of constitutional and familial character. MM Chediak, Rev Hematol 1952 7 362 367 13004553
3. Congenital gigantism of peroxidase granules: the first case ever reported of qualitative abnormity of peroxidase. O Higashi, Tohoku J Exp Med 1954 59 315 332 13169161
4. Chédiak and Higashi's disease: probable identity of a new leucocytal anomaly (Chédiak) and congenital gigantism of peroxidase granules (Higashi). A Sato, Tohoku J Exp Med 1995 61 201 210
5. Chediak-Higashi syndrome. J Kaplan, I De Domenico, DM Ward, Curr Opin Hematol 2008 15 22 29 18043242
6. Identification of the homologous beige and Chediak-Higashi syndrome genes. MDFS Barbosa, QA Nguyen, VT Tchernev, JA Ashley, JC Detter, SM Blaydes, SJ Brandt, D Chotai, C Hodgman, RCE Solari, M Lovett, SF Kingsmore, Nature 1996 382 262 265 8717042
7. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. DL Nagle, MA Karim, EA Woolf, L Holmgren, P Bork, DJ Misumi, SH McGrail, BJ Dussault Jr, CM Perou, RE Boissy, GM Duyk, RA Spritz, KJ Moore, Nat Genet 1996 14 307 311 8896560
8. Identification of the murine beige gene by YAC complementation and positional cloning. CM Perou, KJ Moore, DL Nagle, DJ Misumi, EA Woolf, SH McGrail, L Holmgren, TH Brody, BJ Dussault Jr, CA Monroe, GM Duyk, RJ Pryor, L Li, MJ Justice, J Kaplan, Nat Genet 1996 13 303 308 8673129
9. The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion. N Durchfort, S Verhoef, MB Vaughn, R Shrestha, D Adam, J Kaplan, DM Ward, Traffic 2012 13 108 119 21985295
10. Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells. C Huynh, D Roth, DM Ward, J Kaplan, NW Andrews, Proc Natl Acad Sci U S A 2004 101 16795 16800 15557559
11. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak- Higashi syndrome) beige mouse. M Ito, A Sato, F Tanabe, E Ishida, Y Takami, S Shigeta, Biochem Biophys Res Commun 1989 160 433 440 2541700
12. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice-a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts. F Tanabe, S-H Cui, M Ito, J Leukoc Biol 2000 67 749 755 10811017
13. Enhanced diacylglycerol production by phospholipase D activation is responsible for abnormal increase in concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mice. H Kasai, F Tanabe, Int Immunopharmacol 2014 21 193 199 24830864
14. A novel single point mutation of the LYST gene in two siblings with different phenotypic features of Chediak Higashi syndrome. Z Kaya, S Ehl, M Albayrak, A Maul-Pavicic, K Schwarz, U Kocak, MA Ergun, T Gursel, Pediatr Blood Cancer 2011 56 1136 1139 21488161
15. Mixed hyperpigmentation and hypopigmentation of iris and choroid in Chediak-Higashi syndrome. M-C Ho, Y-T Hsieh, J AAPOS 2013 17 558 560 24160983
16. Neutrophil homeostasis and periodontal health in children and adults. E Hajishengallis, G Hajishengallis, J Dent Res 2014 93 231 237 24097856
17. Accelerated phase of chediak higashi syndrome mimicking lymphoma-a case report. AR Nargund, DS Madhumathi, CS Premalatha, CR Rao, L Appaji, V Lakshmidevi, J Pediatr Hematol Oncol 2010 32 223 e226 20661157
18. Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. I Sánchez-Guiu, AI Antón, N García-Barberá J Navarro-Fernández, C Martínez, JL Fuster, JM Couselo, FJ Ortuño, V Vicente, J Rivera, ML Lozano, Eur J Haematol 2014 92 49 58 24112114
19. Accelerated Phase at Initial Presentation in Chédiak-Higashi Syndrome: Is It Really Uncommon? S Gajendra, RR Das, A Chopra, A Singh, R Seth, Pediatr Hematol Oncol 2014 31 382 385 24274591
20. Chediak-Higashi syndrome presenting in accelerated phase. T Imran, L Zafar, M Rehan, A Nasir, PA Tariq, I Batool, J Coll Physicians Surg Pak 2012 22 539 541 22868026
21. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. L Dotta, S Parolini, A Prandini, G Tabellini, M Antolini, SF Kingsmore, R Badolato, Orphanet J Rare Dis 2013 8 168 24134793
22. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. M Rudelius, A Osanger, S Kohlmann, M Augustin, G Piontek, U Heinzmann, G Jennen, A Russ, K Matiasek, G Stumm, J Schlegel, Acta Neuropathol 2006 112 267 276 16791600
23. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. YT Bryceson, D Pende, A Maul-Pavicic, KC Gilmour, H Ufheil, T Vraetz, SC Chiang, S Marcenaro, R Meazza, I Bondzio, D Walshe, G Janka, K Lehmberg, K Beutel, UZ Stadt, N Binder, M Arico, L Moretta, J-I Henter, S Ehl, Blood 2012 119 2754 2763 22294731
24. Disorders of neutrophil function: an overview. MC Dinauer, Methods Mol Biol 2014 1124 501 515 24504971
25. Molecular determinants of platelet delta storage pool deficiencies: an update. J Masliah-Planchon, L Darnige, S Bellucci, Br J Haematol 2013 160 5 11 23025459
26. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. M Tardieu, C Lacroix, B Neven, P Bordigoni, G De Saint Basile, S Blanche, A Fischer, Blood 2005 106 40 42 15790783
27. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. B Jessen, A Maul-Pavicic, H Ufheil, T Vraetz, A Enders, K Lehmberg, A Längler, U Gross-Wieltsch, A Bay, Z Kaya, YT Bryceson, E Koscielniak, S Badawy, G Davies, M Hufnagel, A Schmitt-Graeff, P Aichele, U Stadt, K Schwarz, S Ehl, Blood 2011 118 4620 4629 21878672
28. Hemophagocytic lymphohistiocytosis (HLH): a review of literature. RS Mehta, RE Smith, Med Oncol 2013 30 740 24105023
29. The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis. A Gupta, S Weitzman, M Abdelhaleem, Pediatr Blood Cancer 2008 50 192 194 18061932
30. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. J-I Henter, A Horne, M Aricó RM Egeler, AH Filipovich, S Imashuku, S Ladisch, K McClain, D Webb, J Winiarski, G Janka, Pediatr Blood Cancer 2007 48 124 131 16937360
31. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. K Lehmberg, S Ehl, Br J Haematol 2013 160 275 287 23206255
32. Hematopoietic cell transplantation for Chediak-Higashi syndrome. M Eapen, CA DeLaat, KS Baker, MS Cairo, MJ Cowan, J Kurtzberg, CG Steward, PA Veys, AH Filipovich, Bone Marrow Transplant 2007 39 411 415 17293882
33. Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein. MA Karim, DL Nagle, HH Kandil, J Bürger, KJ Moore, RA Spritz, Hum Mol Genet 1997 6 1087 1089 9215679
34. Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. MA Karim, K Suzuki, K Fukai, J Oh, DL Nagle, KJ Moore, E Barbosa, T Falik-Borenstein, A Filipovich, Y Ishida, S Kivrikko, C Klein, F Kreuz, A Levin, H Miyajima, J Regueiro, C Russo, E Uyama, O Vierimaa, RA Spritz, Am J Med Genet 2002 108 16 22 11857544
35. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. S Certain, F Barrat, E Pastural, F Le Deist, J Goyo-Rivas, N Jabado, M Benkerrou, R Seger, E Vilmer, G Beullier, K Schwarz, A Fischer, G De Saint Basile, Blood 2000 95 979 983 10648412
36. Molecular analysis and clinical aspects of four patients with Chediak-Higashi syndrome (CHS). E Scherber, K Beutel, R Ganschow, A Schulz, G Janka, UZ Stadt, Clin Genet 2009 76 409 412 19650863
37. Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease. JD Weisfeld-Adams, L Mehta, JC Rucker, FR Dembitzer, A Szporn, FD Lublin, WJ Introne, V Bhambhani, MC Chicka, C Cho, Orphanet J Rare Dis 2013 8 46 23521865
38. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. MDFS Barbosa, FJ Barrat, VT Tchernev, QA Nguyen, VS Mishra, SD Colman, E Pastural, R Dufourcq-Lagelouse, A Fischer, RF Holcombe, MR Wallace, SJ Brandt, G De Saint Basile, SF Kingsmore, Hum Mol Genet 1997 6 1091 1098 9215680
39. Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. W Westbroek, D Adams, M Huizing, A Koshoffer, H Dorward, B Tinloy, J Parkes, A Helip-Wooley, R Kleta, E Tsilou, P Duvernay, KB Digre, DJ Creel, JG White, RE Boissy, WA Gahl, J Invest Dermatol 2007 127 2674 2677 17554367
40. Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1. R Dufourcq-Lagelouse, N Lambert, M Duval, G Viot, E Vilmer, A Fischer, M Prieur, G De Saint Basile, Eur J Hum Genet 1999 7 633 637 10482950
41. Chediak-Higashi syndrome presenting as young-onset levodopa-responsive parkinsonism. V Bhambhani, WJ Introne, C Lungu, A Cullinane, C Toro, Mov Disord 2013 28 127 129 23436631
42. Novel Heterogenous CHS1 Mutations Identified in Five Japanese Patients with Chediak-Higashi Syndrome. F Tanabe, H Kasai, M Morimoto, S Oh, H Takada, T Hara, M Ito, Case Rep Med 2010 2010 rticle ID 464671
43. Chediak-Higashi syndrome with early developmental delay resulting from paternal heterodisomy of chromosome 1. I Manoli, G Golas, W Westbroek, T Vilboux, TC Markello, W Introne, D Maynard, B Pederson, T Ekaterini, MB Jordan, PS Hart, JG White, WA Gahl, M Huizing, Am J Med Genet 2010 152A 1474 1483 20503323
44. Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation. H Shimazaki, J Honda, T Naoi, M Namekawa, I Nakano, M Yazaki, K Nakamura, K Yoshida, S-I Ikeda, H Ishiura, Y Fukuda, Y Takahashi, J Goto, S Tsuji, Y Takiyama, J Neurol Neurosurg Psychiatry 2014 85 1024 1028 24521565
45. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. W Zarzour, R Kleta, H Frangoul, P Suwannarat, A Jeong, YK Su, AS Wayne, M Gunay-Aygun, J White, AH Filipovich, WA Gahl, Mol Genet Metab 2005 85 125 132 15896657
46. Two novel mutations identified in an African-American child with Chediak-Higashi syndrome. K Morrone, Y Wang, M Huizing, E Sutton, JG White, WA Gahl, K Moody, Case Rep Med 2010 2010 rticle ID 967535
47. Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome. C Ogimi, R Tanaka, T Arai, A Kikuchi, R Hanada, T Oh-ishi, Pediatr Blood Cancer 2011 57 677 680 21681939
48. Chediak-Higashi Syndrome: Novel Mutation of the CHS1/LYST Gene in 3 Omani Patients. S Al-Tamemi, S Al-Zadjali, F Al-Ghafri, D Dennison, J Pediatr Hematol Oncol 2014 36 248 50 24072239
49. Chediak-Higashi syndrome: pathognomonic feature. H Antunes, A Pereira, I Cunha, Lancet 2013 382 1514 23541537
50. Inherited defects in lymphocyte cytotoxic activity. JP Pachlopnik Schmid, M Côte, MM Ménager, A Burgess, N Nehme, G Ménasché A Fischer, BG De Saint, Immunol Rev 2010 235 10 23 20536552
51. Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan. K Nagai, F Ochi, K Terui, M Maeda, S Ohga, H Kanegane, T Kitoh, K Kogawa, N Suzuki, S Ohta, Y Ishida, T Okamura, H Wakiguchi, M Yasukawa, E Ishii, Pediatr Blood Cancer 2013 60 1582 1586 23804531
52. Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice. B Jessen, T Kögl, FE Sepulveda, G de Saint Basile, P Aichele, S Ehl, Front Immunol 2013 4 448 24379813
53. Congenital disorders associated with platelet dysfunctions. P Nurden, AT Nurden, Thromb Haemost 2008 99 253 263 18278172
54. Platelet function in the Chediak-Higashi syndrome. GR Buchanan, RI Handin, Blood 1976 47 941 948 1276475
55. Cognitive and psychosocial function post hematopoietic stem cell transplantation in children with hemophagocytic lymphohistiocytosis. J Jackson, P Titman, S Butler, K Bond, A Rao, P Veys, R Chiesa, A Leiper, L Riley, K Gilmour, P Amrolia, K Rao, J Allergy Clin Immunol 2013 132 889 895 23987797
56. Primary immunodeficiency diseases: a practical guide for clinicians. SE Turvey, FA Bonilla, AK Junker, Postgrad Med J 2009 85 660 666 20075404
57. Clinical manifestations and outcomes of pediatric chronic neutropenia. C Wan, H-H Yu, M-Y Lu, J-H Lee, L-C Wang, Y-T Lin, Y-H Yang, B-L Chiang, J Formos Med Assoc 2012 111 220 227 22526211
58. Effect of a thiol proteinase inhibitor, E-64-d, on susceptibility to infection with Staphylococcus aureus in Chediak-Higashi syndrome (beige) mice. M Morimoto, F Tanabe, H Kasai, M Ito, Int Immunopharmacol 2007 7 973 980 17499200
59. Improvement of deficient natural killer activity and delayed bactericidal activity by a thiol proteinase inhibitor, E-64-d, in leukocytes from Chediak-Higashi syndrome patients in vitro. F Tanabe, H Kasai, L He, T Kin, T Fujikado, T Kumamoto, T Hara, T Iwata, M Ito, Int Immunopharmacol 2009 9 366 370 19185618
60. Common management issues in pediatric patients with mild bleeding disorders. SH O'Brien, Semin Thromb Hemost 2012 38 720 726 23034827
61. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. PHB Bolton-Maggs, EA Chalmers, PW Collins, P Harrison, S Kitchen, RJ Liesner, A Minford, AD Mumford, LA Parapia, DJ Perry, SP Watson, JT Wilde, MD Williams, Br J Haematol 2006 135 603 633 17107346
62. Chediak-Higashi syndrome in pregnancy. FV Price, RS Legro, M Watt-Morse, SS Kaplan, Obstet Gynecol 1992 79 804 806 1565370
63. Adult Chédiak-Higashi syndrome presenting as parkinsonism and dementia. E Uyama, T Hirano, K Ito, H Nakashima, M Sugimoto, M Naito, M Uchino, M Ando, Acta Neurol Scand 1994 89 175 183 8030398
64. Adult Chediak-Higashi parkinsonian syndrome with dystonia. RA Hauser, J Friedlander, MJ Baker, J Thomas, KS Zuckerman, Mov Disord 2000 15 705 708 10928582
65. Chediak-Higashi syndrome with parkinsonism. L Silveira-Moriyama, TS Moriyama, TVB Gabbi, R Ranvaud, ER Barbosa, Mov Disord 2004 19 472 475 15077248
66. Chediak-Higashi syndrome with progressive visual loss. K Sayanagi, T Fujikado, T Onodera, Y Tano, Jpn J Ophthalmol 2003 47 304 306 12782169
67. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. J-I Henter, A Samuelsson-Horne, M Aricò R Maarten Egeler, G Elinder, AH Filipovich, H Gadner, S Imashuku, D Komp, S Ladisch, D Webb, G Janka, Blood 2002 100 2367 2373 12239144
68. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. K Beutel, U Gross-Wieltsch, T Wiesel, UZ Stadt, G Janka, HJ Wagner, Pediatr Blood Cancer 2009 53 184 190 19353621
69. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. RA Marsh, CE Allen, KL Mcclain, JL Weinstein, J Kanter, J Skiles, ND Lee, SP Khan, J Lawrence, JQ Mo, JJ Bleesing, AH Filipovich, MB Jordan, Pediatr Blood Cancer 2013 60 101 109 22522603
70. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. N Mahlaoui, M Ouachée-Chardin, GDS Basile, B Neven, C Picard, S Blanche, A Fischer, Pediatrics 2007 120 622 e628 17698967
71. How I treat hemophagocytic lymphohistiocytosis. MB Jordan, CE Allen, S Weitzman, AH Filipovich, KL McClain, Blood 2011 118 4041 4052 21828139
72. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. Y Wang, Z Wang, L Wu, J Zhang, J Wang, L Yan, Ann Hematol 2013 92 1695 1699 23778995
73. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis. M Yamamoto, T Hori, N Hatakeyama, K Igarashi, N Inazawa, H Tsutsumi, N Suzuki, Indian J Pediatr 2014 81 288 291 23912823
74. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. A Horne, G Janka, RM Egeler, H Gadner, S Imashuku, S Ladisch, F Locatelli, SM Montgomery, D Webb, J Winiarski, AH Filipovich, J-I Henter, Br J Haematol 2005 129 622 630 15916685
75. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation. M Sparber-Sauer, M Hönig, AS Schulz, U Zur Stadt, C Schütz, KM Debatin, W Friedrich, Bone Marrow Transplant 2009 44 333 338 19252534
76. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. M Ouachée-Chardin, C Elie, G de Saint Basile, F Le Deist, N Mahlaoui, C Picard, B Neven, JL Casanova, M Tardieu, M Cavazzana-Calvo, S Blanche, A Fischer, Pediatrics 2006 117 743 50 16549504
77. In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome? M Ayas, A Al-Ghonaium, Bone Marrow Transplant 2007 40 603 17637689
78. Reduced-intensity conditioning (RIC) significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. RA Marsh, G Vaughn, M-O Kim, D Li, S Jodele, S Joshi, PA Mehta, SM Davies, MB Jordan, JJ Bleesing, AH Filipovich, Blood 2010 116 5824 5831 20855862
79. Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward. RA Marsh, MB Jordan, AH Filipovich, Br J Haematol 2011 154 556 563 21707584
80. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. M Nishi, R Nishimura, N Suzuki, A Sawada, T Okamura, N Fujita, R Kanai, J Yano, S Adachi, T Yasumi, E Sato, K Yasutomo, E Ishii, S Ohga, Am J Hematol 2012 87 637 639 22488407